rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Fouad Namouni

Director

Company insider

Files Form 4 as: Director, Vor Biopharma; President, R & D, Blueprint Medicines; Director, Aprea Therapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
38
Buys
0
Sells
8
Bought
$0
Sold
$2.2M
Companies
3
Companies where not an officer
2
First trade
26 Jun 2020
Last trade
11 Jun 2026
Last filed
12 Jun 2026

Companies traded

Where they are an officer
Blueprint MedicinesOfficer · last 17 Jul 20250 buys · 8 sells
Everywhere else they filed: board seats, 10% stakes, other companies
VOR Vor BiopharmaDirector · Biotechnology · last 11 Jun 20260 buys · 0 sells
APRE Aprea TherapeuticsDirector · Biotechnology · last 30 Jun 20210 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
11 Jun 2026filed 12 Jun 2026VOR Vor Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—56,549 at $0.00filing
11 Jun 2026filed 12 Jun 2026VOR Vor Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—56,549 at $0.00filing
17 Jul 2025filed 21 Jul 2025Blueprint Medicinesoption or derivativeSEC FORM 4 Code D—65,000filing
17 Jul 2025filed 21 Jul 2025Blueprint Medicinesoption or derivativeSEC FORM 4 Code D—26,125filing
17 Jul 2025filed 21 Jul 2025Blueprint Medicinesoption or derivativeSEC FORM 4 Code D—30,000filing
17 Jul 2025filed 21 Jul 2025Blueprint Medicinesoption or derivativeSEC FORM 4 Code D—30,000filing
17 Jul 2025filed 21 Jul 2025Blueprint Medicinesoption or derivativeSEC FORM 4 Code D—30,000filing
17 Jul 2025filed 21 Jul 2025Blueprint Medicinesoption or derivativeSEC FORM 4 Code D—26,400filing
17 Jul 2025filed 21 Jul 2025Blueprint MedicinesSEC FORM 4 Code A—39,456filing
17 Jul 2025filed 21 Jul 2025Blueprint MedicinesSEC FORM 4 Code D—83,281filing
17 Jul 2025filed 21 Jul 2025Blueprint MedicinesSEC FORM 4 Code U—31,956filing
22 May 2025filed 23 May 2025VOR Vor Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
5 Mar 2025filed 7 Mar 2025Blueprint MedicinesSEC FORM 4 Sold$576K6,489 at $88.80filing
1 Mar 2025filed 4 Mar 2025Blueprint Medicinesoption or derivativeSEC FORM 4 Code A—26,400 at $0.00filing
1 Mar 2025filed 4 Mar 2025Blueprint MedicinesSEC FORM 4 Code A—13,200 at $0.00filing
3 Oct 2024filed 4 Oct 2024Blueprint MedicinesSEC FORM 4 Sold$324K3,633 at $89.32filing
23 May 2024filed 28 May 2024VOR Vor Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
30 Apr 2024filed 2 May 2024VOR Vor Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—60,000 at $0.00filing
7 Mar 2024filed 11 Mar 2024Blueprint MedicinesSEC FORM 4 Sold$397K4,377 at $90.69filing
1 Mar 2024filed 6 Mar 2024Blueprint Medicinesoption or derivativeSEC FORM 4 Code A—30,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed8

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.